Molecular breast imaging in clinical practice

Elizabeth H. Dibble, Katie N. Hunt, Eric C. Ehman, Michael K. O'Connor

Research output: Contribution to journalReview articlepeer-review


OBjective: The purpose of this article is to review clinical uses and image interpretation of molecular breast imaging (MBI) and clarify radiation risks. COnclusion: MBI detects additional cancers compared with conventional imaging in women with dense breasts and those with elevated risk of breast cancer. Its role as an imaging biomarker of cancer risk and in assessing neoadjuvant chemotherapy response is growing. Radiation risk is minimal; benefit-to-risk ratio is similar to that of mammography. MBI is low cost, well tolerated, and easily adapted into clinical practice.

Original languageEnglish (US)
Pages (from-to)277-284
Number of pages8
JournalAmerican Journal of Roentgenology
Issue number2
StatePublished - Aug 2020


  • Breast cancer
  • Breast imaging
  • Dense breasts
  • MBI
  • Molecular breast imaging
  • Screening

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Molecular breast imaging in clinical practice'. Together they form a unique fingerprint.

Cite this